Biden eyes drug pricing, expert laments ‘failure of democracy’

Despite pressure from consecutive presidential administrations, prescription drug pricing remains an expensive issue for millions of Americans.

“Health care swamps all other sectors of the economy in terms of the amount of lobbying that goes into it,” Shawn Gremminger, director of health policy for Purchaser Business Group on Health, told Yahoo Finance. “The biopharmaceutical sector is by far the sector of the health care lobbying community that spends the most money, which means they are very successful at stopping legislation that might take a chunk out of their profit margin.”

Click here to read the article.